NEW YORK and SAN FRANCISCO, Jan. 8, 2015 /PRNewswire/ -- The 7th Annual Biotech Showcase™ launches next week in San Francisco amid a torrent of good news about the biotech industry, as it has been reported this week that IPOs, M&As, venture investment and drug approvals all exceeded expectations in 2014.
More than 2,000 delegates, including qualified private and public equity investors, industry analysts, bankers, pharmaceutical and biotechnology industry executives, are registered for the Biotech Showcase, which will be held at the Parc 55 Wyndham San Francisco – Union Square from January 12 - 14, 2015. The event will feature presentations by more than 200 of the most innovative small to mid-sized biotech, specialty pharmaceutical and molecular diagnostic companies, of which 70% are publicly traded.
Biotech Showcase will also feature business workshops and plenary sessions that will explore topics key to continued success and growth of the biotech industry, including:
- The state of public and private financial markets
- Therapeutic advances in key areas, such as cancer immunotherapy and Type 1 diabetes
- How to manage the regulatory thicket of the FDA, SEC, CMS and other agencies
- The 3rd Annual Edition of The Life Sciences Report 2015 Small-Cap Watchlist
Attendees are also welcome to register for the "Biotech Showcase pre-event: The tactics of closing funding deals," to be held on Sunday, January 11. The workshop is designed for junior executives and is focused on strategic discussion for securing funding at all levels. Registration for the Biotech Showcase pre-event is separate from the main conference's primary registration.
Biotech Showcase 2015 registration information is available online.
About Biotech Showcase 2015:
Biotech Showcase is an investor conference devoted to providing private and small- and mid-cap biotechnology companies an opportunity to present to and meet with investors and biopharmaceutical executives during the course of one of the largest annual healthcare conferences that attracts investors and biopharmaceutical executives from around the world.
Biotech Showcase is co-produced by Demy-Colton Life Sciences Advisors and EBD Group.
About Demy-Colton Life Science Advisors
Demy-Colton Life Science Advisors is focused exclusively on facilitating the growth of the life science industry. Demy-Colton has developed a number of high-value conferences to address the business and development needs of the biotechnology industry; it provides partnering services and it has helped launch a unique investor website and newsletter.
Jason Rando, Exec. Vice President & COO
Tiberend Strategic Advisors, Inc.
About EBD Group
EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group's partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.
SOURCE Demy-Colton Life Science Advisors